[CYCC] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -11.37%
YoY- 10.77%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,124 -9,000 -6,110 -5,559 -5,246 -6,491 -5,985 12.32%
Tax -1,320 -1,581 -1,014 -984 -1,138 -1,197 -998 20.51%
NP -5,804 -7,419 -5,096 -4,575 -4,108 -5,294 -4,987 10.65%
Tax Rate - - - - - - - -
Total Cost 5,804 7,419 5,096 4,575 4,108 5,294 4,987 10.65%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -6.94 -8.87 -0.41 -0.45 -0.41 -0.54 -0.53 456.42%
EPS Diluted -6.94 -8.87 -0.41 -0.45 -0.41 -0.54 -0.53 456.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.